REPORT ID 2353

United States Estrogen Receptor Beta Market Report 2017

Publish Date
8-Dec-17
Pages
106
Format
Electronic (PDF)

In this report, the United States Estrogen Receptor Beta market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Estrogen Receptor Beta in these regions, from 2012 to 2022 (forecast).

United States Estrogen Receptor Beta market competition by top manufacturers/players, with Estrogen Receptor Beta sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Acadia Pharmaceuticals Inc
    AstraZeneca Plc
    Atossa Genetics Inc
    Chamaeleo Pharma NV
    Eli Lilly and Company
    Endece LLC
    EndoCeutics Inc
    Karo Pharma AB
    Kissei Pharmaceutical Co Ltd
    MEI Pharma Inc
    Mithra Pharmaceuticals SA
    Oasmia Pharmaceutical AB

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Erteberel
    Estetrol
    Fosfestrol
    Fulvestrant
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Women's Health
    Metabolic Disorder
    Dermatology
    Immunology
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Estrogen Receptor Beta Market Report 2017
1 Estrogen Receptor Beta Overview
    1.1 Product Overview and Scope of Estrogen Receptor Beta
    1.2 Classification of Estrogen Receptor Beta by Product Category
        1.2.1 United States Estrogen Receptor Beta Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Estrogen Receptor Beta Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Erteberel
        1.2.4 Estetrol
        1.2.5 Fosfestrol
        1.2.6 Fulvestrant
        1.2.7 Others
    1.3 United States Estrogen Receptor Beta Market by Application/End Users
        1.3.1 United States Estrogen Receptor Beta Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Women's Health
        1.3.3 Metabolic Disorder
        1.3.4 Dermatology
        1.3.5 Immunology
        1.3.6 Others
    1.4 United States Estrogen Receptor Beta Market by Region
        1.4.1 United States Estrogen Receptor Beta Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Estrogen Receptor Beta Status and Prospect (2012-2022)
        1.4.3 Southwest Estrogen Receptor Beta Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Estrogen Receptor Beta Status and Prospect (2012-2022)
        1.4.5 New England Estrogen Receptor Beta Status and Prospect (2012-2022)
        1.4.6 The South Estrogen Receptor Beta Status and Prospect (2012-2022)
        1.4.7 The Midwest Estrogen Receptor Beta Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Estrogen Receptor Beta (2012-2022)
        1.5.1 United States Estrogen Receptor Beta Sales and Growth Rate (2012-2022)
        1.5.2 United States Estrogen Receptor Beta Revenue and Growth Rate (2012-2022)

2 United States Estrogen Receptor Beta Market Competition by Players/Suppliers
    2.1 United States Estrogen Receptor Beta Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Estrogen Receptor Beta Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Estrogen Receptor Beta Average Price by Players/Suppliers (2012-2017)
    2.4 United States Estrogen Receptor Beta Market Competitive Situation and Trends
        2.4.1 United States Estrogen Receptor Beta Market Concentration Rate
        2.4.2 United States Estrogen Receptor Beta Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Estrogen Receptor Beta Manufacturing Base Distribution, Sales Area, Product Type

3 United States Estrogen Receptor Beta Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Estrogen Receptor Beta Sales and Market Share by Region (2012-2017)
    3.2 United States Estrogen Receptor Beta Revenue and Market Share by Region (2012-2017)
    3.3 United States Estrogen Receptor Beta Price by Region (2012-2017)

4 United States Estrogen Receptor Beta Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Estrogen Receptor Beta Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Estrogen Receptor Beta Revenue and Market Share by Type (2012-2017)
    4.3 United States Estrogen Receptor Beta Price by Type (2012-2017)
    4.4 United States Estrogen Receptor Beta Sales Growth Rate by Type (2012-2017)

5 United States Estrogen Receptor Beta Sales (Volume) by Application (2012-2017)
    5.1 United States Estrogen Receptor Beta Sales and Market Share by Application (2012-2017)
    5.2 United States Estrogen Receptor Beta Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Estrogen Receptor Beta Players/Suppliers Profiles and Sales Data
    6.1 Acadia Pharmaceuticals Inc
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Estrogen Receptor Beta Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Acadia Pharmaceuticals Inc Estrogen Receptor Beta Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 AstraZeneca Plc
        6.2.2 Estrogen Receptor Beta Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 AstraZeneca Plc Estrogen Receptor Beta Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Atossa Genetics Inc
        6.3.2 Estrogen Receptor Beta Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Atossa Genetics Inc Estrogen Receptor Beta Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Chamaeleo Pharma NV
        6.4.2 Estrogen Receptor Beta Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Chamaeleo Pharma NV Estrogen Receptor Beta Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Eli Lilly and Company
        6.5.2 Estrogen Receptor Beta Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Eli Lilly and Company Estrogen Receptor Beta Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Endece LLC
        6.6.2 Estrogen Receptor Beta Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Endece LLC Estrogen Receptor Beta Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 EndoCeutics Inc
        6.7.2 Estrogen Receptor Beta Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 EndoCeutics Inc Estrogen Receptor Beta Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Karo Pharma AB
        6.8.2 Estrogen Receptor Beta Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Karo Pharma AB Estrogen Receptor Beta Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Kissei Pharmaceutical Co Ltd
        6.9.2 Estrogen Receptor Beta Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Kissei Pharmaceutical Co Ltd Estrogen Receptor Beta Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 MEI Pharma Inc
        6.10.2 Estrogen Receptor Beta Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 MEI Pharma Inc Estrogen Receptor Beta Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Mithra Pharmaceuticals SA
    6.12 Oasmia Pharmaceutical AB

7 Estrogen Receptor Beta Manufacturing Cost Analysis
    7.1 Estrogen Receptor Beta Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Estrogen Receptor Beta

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Estrogen Receptor Beta Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Estrogen Receptor Beta Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Estrogen Receptor Beta Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Estrogen Receptor Beta Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Estrogen Receptor Beta Sales Volume Forecast by Type (2017-2022)
    11.3 United States Estrogen Receptor Beta Sales Volume Forecast by Application (2017-2022)
    11.4 United States Estrogen Receptor Beta Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer